Clinical trial
A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in…
NCT00395070 · Vical, Industry · Completed
Key facts
| NCT number | NCT00395070 |
|---|---|
| Title | A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma |
| Official title | A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Treatment With 2 mg Intralesional Allovectin-7® Compared to Dacarbazine (DTIC) or Temozolomide (TMZ) in Subjects With Recurrent Metastatic Melanoma |
| Lead sponsor | Vical, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Metastatic Melanoma |
| Intervention type | Biological, Drug |
| Interventions | Allovectin-7®, Dacarbazine (DTIC), Temozolomide (TMZ) |
| Enrollment | 390 |
| Start date | Oct 1, 2006 |
| Primary completion | Mar 1, 2012 |
| Completion | Jul 1, 2013 |
| First posted | Nov 2, 2006 |
| Last update posted | Sep 13, 2013 |
| Countries | Belgium, Brazil, Canada, France, Germany, Israel, Italy, Netherlands, Poland, Russia, Spain, Switzerland and 2 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: